CTRI/2019/01/017011已完成未知
A comparative study of efficacy of 0.05% Tazarotene gel against 0.1% Adapalene gel in patients of facial Acne Vulgaris
Dr Sanmitra Aiholli0 个研究点目标入组 82 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 Facial acne vulgaris of mild to moderate severity.
- •2 Patients willing to undergo treatment and come for follow up.
排除标准
- •1 Facial acne vulgaris of severe type
- •2 Pregnant women & women who are planning to conceive.
研究者
相似试验
进行中（未招募）
不适用
Efficacy and safety of 0,1%, 0,5% and 1% TAZAROTENE nail lacquer formulation versus vehicle in nail psoriasis.International, multicenter, double-blind, randomized study of four parallel groups. - Dose ranging for Tazarotene nail lacquerPsoriasis of the skin is frequently accompanied by nail changes: between 10 and 78% of psoriatic patients suffer from changes of the nails. More than 50% of patients with nail psoriasis have pain because of nail changes, and nearly 60% experience limitations in daily activities.Conventional therapies (e.g., topical agents, triamcinolone acetonide injections, cyclosporine, methotrexate, retinoids, and phototherapy) have limited efficacy, and many have tolerability concerns.MedDRA version: 7.1Level: PTClassification code 10028703EUCTR2004-004825-87-HUPierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre184
进行中（未招募）
不适用
Efficacy and safety of 0,1%, 0,5% and 1% TAZAROTENE nail lacquer formulation versus vehicle in nail psoriasis.International, multicenter, double-blind, randomized study of four parallel groups. - Dose ranging for Tazarotene nail lacquerEUCTR2004-004825-87-DEPierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre184
进行中（未招募）
不适用
Efficacy and safety of 0,1%, 0,5% and 1% TAZAROTENE nail lacquer formulation versus vehicle in nail psoriasis.International, multicenter, double-blind, randomized study of four parallel groups. - Dose ranging for Tazarotene nail lacquerPsoriasis of the skin is frequently accompanied by nail changes: between 10 and 78% of psoriatic patients suffer from changes of the nails. More than 50% of patients with nail psoriasis have pain because of nail changes, and nearly 60% experience limitations in daily activities.Conventional therapies (e.g., topical agents, triamcinolone acetonide injections, cyclosporine, methotrexate, retinoids, and phototherapy) have limited efficacy, and many have tolerability concerns.MedDRA version: 7.1Level: PTClassification code 10028703EUCTR2004-004825-87-CZPierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre184
尚未招募
3 期
Comparison between tazarotene 0.05 percent gel and adapalene 0.1 percent gel in acne patients.CTRI/2024/06/069345Dr Sharwari Jaiswal
已完成
3 期
Generic Tazarotene Cream, 0.05% for the Treatment of Plaque PsoriasisPlaque PsoriasisNCT02160665G & W Laboratories Inc.866